{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T17:27:15Z","timestamp":1769448435861,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K06438"],"award-info":[{"award-number":["JP23K06438"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation for Promotion of Cancer Research in Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04417-1","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T07:11:42Z","timestamp":1769411502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Selective MYC 5\u2032 amplification in postirradiation\/lymphedema-associated angiosarcoma"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6991-747X","authenticated-orcid":false,"given":"Naohiro","family":"Makise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouko","family":"Hayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikiya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Kamoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Yonemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Kawazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinobu","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"4417_CR1","first-page":"785","volume-title":"Enzinger and Weiss\u2019s soft tissue tumors","author":"JR Goldblum","year":"2020","unstructured":"Goldblum JR, Folpe AL, Weiss SW (2020) Malignant vascular tumors. In: Weiss SW, Goldblum JR, Folpe AL (eds) Enzinger and Weiss\u2019s soft tissue tumors, 7th edn. Mosby Elsevier, Philadelphia, PA, pp 785\u2013816","edition":"7"},{"key":"4417_CR2","unstructured":"Thway K, Billings SD (2020) Angiosarcoma. In: WHO classification of tumours editorial board (ed) WHO classification of tumours: soft tissue and bone tumours, 5th edn. Lyon, France: International Agency for Research on Cancer, pp 176\u2013178."},{"key":"4417_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/00000478-199806000-00005","volume":"22","author":"JM Meis-Kindblom","year":"1998","unstructured":"Meis-Kindblom JM, Kindblom LG (1998) Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol 22:683\u2013697. https:\/\/doi.org\/10.1097\/00000478-199806000-00005","journal-title":"Am J Surg Pathol"},{"key":"4417_CR4","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1002\/1097-0142(19950615)75:123C2867::aid-cncr28207512123E3.0.co;2-8","volume":"75","author":"M Ohsawa","year":"1995","unstructured":"Ohsawa M, Naka N, Tomita Y, Kawamori D, Kanno H, Aozasa K (1995) Use of immunohistochemical procedures in diagnosing angiosarcoma. Evaluation of 98 cases. Cancer 75:2867\u20132874. https:\/\/doi.org\/10.1002\/1097-0142(19950615)75:123C2867::aid-cncr28207512123E3.0.co;2-8","journal-title":"Cancer"},{"key":"4417_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/pas.0b013e318206b67b","volume":"35","author":"M Miettinen","year":"2011","unstructured":"Miettinen M, Wang ZF, Paetau A et al (2011) ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. Am J Surg Pathol 35:432\u2013441. https:\/\/doi.org\/10.1097\/pas.0b013e318206b67b","journal-title":"Am J Surg Pathol"},{"key":"4417_CR6","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/modpathol.2011.65","volume":"24","author":"GJ van Leenders","year":"2011","unstructured":"van Leenders GJ, Boormans JL, Vissers CJ et al (2011) Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice. Mod Pathol 24:1128\u20131138. https:\/\/doi.org\/10.1038\/modpathol.2011.65","journal-title":"Mod Pathol"},{"key":"4417_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/jcp-2024-210009","volume":"78","author":"A Ito","year":"2025","unstructured":"Ito A, Ito Y, Ikeda H et al (2025) CD31 expression in human cancers: a pan-cancer immunohistochemical study. J Clin Pathol 78:623\u2013628. https:\/\/doi.org\/10.1136\/jcp-2024-210009","journal-title":"J Clin Pathol"},{"key":"4417_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.humpath.2013.11.002","volume":"45","author":"PS Ginter","year":"2014","unstructured":"Ginter PS, Mosquera JM, MacDonald TY, D\u2019Alfonso TM, Rubin MA, Shin SJ (2014) Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites. Hum Pathol 45:709\u2013716. https:\/\/doi.org\/10.1016\/j.humpath.2013.11.002","journal-title":"Hum Pathol"},{"key":"4417_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW (2022) The MYC oncogene\u2014the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol 19:23\u201336. https:\/\/doi.org\/10.1038\/s41571-021-00549-2","journal-title":"Nat Rev Clin Oncol"},{"key":"4417_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102154","volume":"94","author":"MJ Duffy","year":"2021","unstructured":"Duffy MJ, O\u2019Grady S, Tang M, Crown J (2021) Myc as a target for cancer treatment. Cancer Treat Rev 94:102154. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102154","journal-title":"Cancer Treat Rev"},{"key":"4417_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.70004","volume":"63","author":"N Makise","year":"2024","unstructured":"Makise N, Lin J, Kageyama H et al (2024) Sporadic breast angiosarcoma with MYC amplification on extrachromosomal circular DNA detected using nanopore sequencing in an adolescent female. Genes Chromosomes Cancer 63:e70004. https:\/\/doi.org\/10.1002\/gcc.70004","journal-title":"Genes Chromosomes Cancer"},{"key":"4417_CR12","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cell.2019.10.039","volume":"179","author":"AR Morton","year":"2019","unstructured":"Morton AR, Dogan-Artun N, Faber ZJ et al (2019) Functional enhancers shape extrachromosomal oncogene amplifications. Cell 179:1330-1341.e13. https:\/\/doi.org\/10.1016\/j.cell.2019.10.039","journal-title":"Cell"},{"key":"4417_CR13","unstructured":"cBioportal for cancer genomics. Memorial Sloan Kettering Cancer Center. www.cbioportal.org\/. Accessed 4 June 2025"},{"key":"4417_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41591-019-0749-z","volume":"26","author":"CA Painter","year":"2020","unstructured":"Painter CA, Jain E, Tomson BN et al (2020) The angiosarcoma project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med 26:181\u2013187. https:\/\/doi.org\/10.1038\/s41591-019-0749-z","journal-title":"Nat Med"},{"key":"4417_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature07829","volume":"459","author":"ND Heintzman","year":"2009","unstructured":"Heintzman ND, Hon GC, Hawkins RD et al (2009) Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459:108\u2013112. https:\/\/doi.org\/10.1038\/nature07829","journal-title":"Nature"},{"key":"4417_CR16","unstructured":"ENCODE project. Stanford University. https:\/\/www.encodeproject.org\/. Accessed 4 June 2025"},{"key":"4417_CR17","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1097\/00000478-200109000-00007","volume":"25","author":"JK McKenney","year":"2001","unstructured":"McKenney JK, Weiss SW, Folpe AL (2001) CD31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am J Surg Pathol 25:1167\u20131173. https:\/\/doi.org\/10.1097\/00000478-200109000-00007","journal-title":"Am J Surg Pathol"},{"key":"4417_CR18","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1073\/pnas.79.24.7837","volume":"79","author":"R Taub","year":"1982","unstructured":"Taub R, Kirsch I, Morton C et al (1982) Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA 79:7837\u20137841. https:\/\/doi.org\/10.1073\/pnas.79.24.7837","journal-title":"Proc Natl Acad Sci USA"},{"key":"4417_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/sj.leu.2403661","volume":"19","author":"S Knezevich","year":"2005","unstructured":"Knezevich S, Ludkovski O, Salski C et al (2005) Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas. Leukemia 19:659\u2013663. https:\/\/doi.org\/10.1038\/sj.leu.2403661","journal-title":"Leukemia"},{"key":"4417_CR20","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1097\/pas.0b013e3181f3e29f","volume":"34","author":"A Valera","year":"2010","unstructured":"Valera A, Balagu\u00e9 O, Colomo L et al (2010) Ig\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol 34:1686\u20131694. https:\/\/doi.org\/10.1097\/pas.0b013e3181f3e29f","journal-title":"Am J Surg Pathol"},{"key":"4417_CR21","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1038\/s41375-018-0154-5","volume":"32","author":"K Sakamoto","year":"2018","unstructured":"Sakamoto K, Katayama R, Asaka R et al (2018) Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response. Leukemia 32:2590\u20132603. https:\/\/doi.org\/10.1038\/s41375-018-0154-5","journal-title":"Leukemia"},{"key":"4417_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/sj.bjc.6603805","volume":"97","author":"A Virtanen","year":"2007","unstructured":"Virtanen A, Pukkala E, Auvinen A (2007) Angiosarcoma after radiotherapy: a cohort study of 332,163 Finnish cancer patients. Br J Cancer 97:115\u2013117. https:\/\/doi.org\/10.1038\/sj.bjc.6603805","journal-title":"Br J Cancer"},{"key":"4417_CR23","first-page":"680","volume":"12","author":"LL Wang","year":"2019","unstructured":"Wang LL, Cui LF, Gao Y, Jiang ZC (2019) Clinicopathologic features of Stewart-Treves syndrome. Int J Clin Exp Pathol 12:680\u2013688","journal-title":"Int J Clin Exp Pathol"},{"key":"4417_CR24","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/carcin\/bgs155","volume":"33","author":"NS Hadj-Hamou","year":"2012","unstructured":"Hadj-Hamou NS, La\u00e9 M, Almeida A et al (2012) A transcriptome signature of endothelial lymphatic cells coexists with the chronic oxidative stress signature in radiation-induced post-radiotherapy breast angiosarcomas. Carcinogenesis 33:1399\u20131405. https:\/\/doi.org\/10.1093\/carcin\/bgs155","journal-title":"Carcinogenesis"},{"key":"4417_CR25","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.trecan.2018.10.003","volume":"4","author":"O Lancho","year":"2018","unstructured":"Lancho O, Herranz D (2018) The myc enhancer-ome: long-range transcriptional regulation of myc in cancer. Trends Cancer 4:810\u2013822. https:\/\/doi.org\/10.1016\/j.trecan.2018.10.003","journal-title":"Trends Cancer"},{"key":"4417_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.celrep.2018.03.056","volume":"23","author":"J Schuijers","year":"2018","unstructured":"Schuijers J, Manteiga JC, Weintraub AS et al (2018) Transcriptional dysregulation of MYC reveals common enhancer-docking mechanism. Cell Rep 23:349\u2013360. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.056","journal-title":"Cell Rep"},{"key":"4417_CR27","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/cas.15651","volume":"114","author":"T Tamura","year":"2023","unstructured":"Tamura T, Ikegami M, Kanemasa Y et al (2023) Selection bias due to delayed comprehensive genomic profiling in Japan. Cancer Sci 114:1015\u20131025. https:\/\/doi.org\/10.1111\/cas.15651","journal-title":"Cancer Sci"},{"key":"4417_CR28","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1158\/1078-0432.CCR-24-3399","volume":"31","author":"J Zhang","year":"2025","unstructured":"Zhang J, Jin Y, Lin H et al (2025) Amplification of extrachromosomal MYC paralogs shapes immunosuppressive tumor microenvironment in small cell lung cancer. Clin Cancer Res 31:4529\u20134542. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-3399","journal-title":"Clin Cancer Res"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04417-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04417-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04417-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T07:11:45Z","timestamp":1769411505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04417-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":28,"alternative-id":["4417"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04417-1","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Chiba Cancer Center Institutional Review Board (M04-005) approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}